Table 1.
Author | Year | Quality Score | Study Type | Modality | Positive Nodal Definition | Reference | Patients (No.) | Stage | N1a NPV | N2a NPV | Overalla,b NPV |
---|---|---|---|---|---|---|---|---|---|---|---|
Farrell et al24 | 2000 | 12 | Retro | PET & CTc | Visuald or sizee | M, Tf | 65 | I | 0.97 | 1.0 | 0.97 |
Konishi et al25 | 2003 | 14 | Retro | PET & CT | Visual or size | T | 41 | I | 0.95 | 0.98 | 0.93 |
Cerfolio et al26 | 2005 | 15 | Pro | PET/CT,g CTh | SUV (≥ 2.5) or size | M, T, EUS-FNA | 140 | I | NA | 0.91 | NA |
Kim et al27 | 2006 | 16 | Pro | PET/CT, CT | Visual or SUV (≥ 3.5) | M, T | 134 | IA | NA | 0.87 | NA |
Lee et al28 | 2007 | 10 | Retro | PET & CT | SUV or size | M, T | 224 | I | NA | 0.93 | NA |
155 | IA | NA | 0.94 | NA | |||||||
69 | IB | NA | 0.91 | NA | |||||||
Veeramachaneni et al29 | 2008 | 11 | Pro | PET & CT | PET-NAi or size | M, T | 108 | IA | 0.94 | 0.95 | 0.90 |
Herth et al30 | 2008 | 15 | Pro | PET & CT | SUV (≥ 2.5) or size | M, T, EBUS-TBNA | 97 | I | 0.97 | 0.94b | 0.91 |
Maeda et al31 | 2009 | 10 | Retro | PET/CT, CT | SUV or size | T | 58 | IA | 0.85 | 0.95 | 0.79 |
Gómez-Caro et al32 | 2010 | 16 | Pro | PET/CT, CT | Visual or size | T | 108 | I | 0.82 | 0.86 | 0.68 |
47 | IA | 0.89 | 0.87 | 0.76 | |||||||
61 | IB | 0.75 | 0.85 | 0.60 | |||||||
Park et al33 | 2010 | 11 | Retro | PET/CT, CT | Visual or size | M, T | 147 | IA | 0.91 | 0.95 | 0.86 |
Abbreviations: EBUS-TBNA = endobronchial ultrasound-guided transbronchial needle aspiration; EUS-FNA = endoscopic ultrasound-guided fine-needle aspiration; M = mediastinoscopy; NA = not available; NPV = negative predictive value; Pro = prospective; Retro = retrospective; SUV = maximum standard uptake value.
N1, hilar nodal metastasis alone; N2, mediastinal nodal metastasis with or without N1 disease; overall, positive nodal disease at N1 or N2.
Includes both N2 and N3 metastases.
Visually reviewed PET and CT side by side.
Visually higher uptake than surrounding normal tissue.
Short axis of lymph nodes.
Thoracotomy with nodal dissection/sampling.
Integrated PET and CT.
Dedicated CT.
Positive PET finding without description of cutoff.